A Common But Complex Condition: Understanding and Treating Atopic Dermamitis

Session Dates

FACULTY

Leon Kircik, MD
Clinical Associate Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York,NY
Indiana University Medical Center, Indianapolis,IN
Medical Director
Physicians Skin Care, PLLC Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville,KY

PROVIDER STATEMENT

 In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Imedex. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

INTENDED LEARNERS

These activities are intended for physician assistants (PAs) and nurse practitioners (NPs) who specialize in dermatology or pediatric medicine as well as other clinicians who manage patients with atopic dermatitis.

lEARNING OBJECTIVES

After participating in this activity, participants should be better able to:

• Describe the “atopic march” in AD and how this feature of AD should inform treatment strategies
• Discuss the effects of uncontrolled AD disease burden on various aspects of patient life
• Outline aspects of guideline recommendations for the management of AD that may be less known to some clinicians
• Characterize the elements of dysbiosis of the skin that have been currently identified
• Identify important features of moisturizers that will be most effective in the treatment of AD
• Summarize efficacy and safety data for biologics and small molecule inhibitory agents that are available for the treatment of AD

Claiming Credit

To be eligible for credit, participants must attend the live course onsite and complete an online evaluation by September 15, 2019. Upon completing the activity, participants will be able to print a certificate or other documentation of credit.

COMMERCIAL SUPPORT

NACCME would like to thank the following company who has supported the "Evaluating the Role of Steroid-Sparing Treatment Approaches in Pediatric Atopic Dermatitis"  through educational grants and/or in-kind support: Pfizer

nursing

This continuing nursing education activity awards 2.50 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 2.50 contact hour.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 2.50 CME credits for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

NACCME and Imedex protect the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and all joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by Imedex, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.